AUTONOMIX MEDICAL INC (AMIX)
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
$1.61-3.01%
Close 2026-11-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
QuarterlyIQ Insights · AMIX
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Worth watching into the next print: this name is a smaller-cap name (higher miss base rate) and has erratic recent earnings surprises. A fundamental tilt, not a price call.
Model as of 2026-11-04 · Compared with 29 industry peers
AMIX — officer change
Dated 2026-11-03
The provided text is only the standard Item 5.02 header and introductory phrase, containing no specific details about a person, role, or action to classify.
Why it matters: The deal brought in cash but also added warrants for future shares. Cash and spending trends show whether funding pressure is easing.
Watch forThe next financial filing shows cash increased from the prior report and operating cash use fell.
Also watch forThe next financial filing shows less cash and higher cash use for operations, or shows new funding tied to shares.
Why it matters: The company lists Nasdaq compliance as a priority. A new notice or proof of compliance would show whether this risk has changed.
Watch forA company filing or Nasdaq notice confirms the listing issue is fixed and the shares meet the rules.
Also watch forA company filing or Nasdaq notice reports a new listing problem or a missed date to fix it.
Why it matters: The company remains loss-making, and loss control has been a stated priority for eight quarters. A smaller loss would show progress.
Watch forThe next reported operating loss is smaller than the prior reported loss of $2.74 million.
Also watch forThe next reported operating loss is larger than $2.74 million.
Why it matters: Management named clinical work and industry ties as priorities. A clear next step would show progress toward testing its device in people.
Supportive ifOn Nov. 11, the company names a clinical study, start date, or next step for its pancreatic cancer pain work.
Worry ifThe Nov. 11 update gives no clinical plan, or says the planned work is delayed.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$372 on $10,000 · ±3.7% | How much price usually moves either way. |
| Bad day | $1,236 loss on $10,000 · 12.4% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,333 loss on $10,000 · 93.3% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.